Bettina Ryll

Bettina Ryll is a prominent figure in the field of melanoma advocacy and patient-centered innovation. As the founder of MPNEurope, a network dedicated to addressing the challenges faced by the European melanoma community, Ryll has been instrumental in fostering collaboration among patient advocates. In addition, Ryll serves as a Strategist for Vision Zero Cancer at the Stockholm School of Economics, focusing on innovative health solutions. Ryll's extensive experience includes roles on several advisory boards, such as the External Scientific Advisory Board for Fondazione IRCCS Istituto Nazionale dei Tumori di Milano and the External Advisory Board for Trinity St. James's Cancer Institute. With a strong academic background, including a PhD in Biomedical Sciences from UCL, Ryll's work spans clinical trial design and drug development through ryll.consulting, further solidifying a commitment to improving cancer care and patient advocacy in Europe.